D.E. Shaw & Co
AERI

D.E. Shaw & Co’s Aerie Pharmaceuticals AERI Stock Holding History

D.E. Shaw & Co’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51,900
Closed -$1.25M – 4378
2019
Q4 		$1.25M Hold
51,900
– – ﹤0.01% 2825
2019
Q3 		$998K Buy
+51,900
New +$1.19M ﹤0.01% 2833

D.E. Shaw & Co's AERI Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 243,976 shares — an estimated $3.69M sold.

D.E. Shaw & Co first reported a position in AERI in Q2 2015 and held it in 12 quarters. The position peaked at $4.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 243,976 Aerie Pharmaceuticals shares in Q4 2022, an estimated $3.69M.
  • D.E. Shaw & Co first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 12 quarters.
  • D.E. Shaw & Co's Aerie Pharmaceuticals position peaked at $4.6M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.